Related Experiment Video
Updated: Feb 22, 2026

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
Published on: June 28, 2019
cAMP assays in GPCR drug discovery
1Thermalin Inc., Cleveland, OH, United States.
G protein-coupled receptors (GPCRs) are key drug targets. GPCR desensitization and cAMP assays offer a sensitive platform for discovering novel functions and drugs for these important cell surface receptors.
Area of Science:
- Biochemistry
- Pharmacology
- Molecular Biology
Background:
- G protein-coupled receptors (GPCRs) represent a significant class of cell surface receptors and are highly druggable targets in medicine.
- Understanding GPCRs' biological effects and therapeutic potential requires deeper insights into biased agonism and functional selectivity.
- Receptor desensitization and resensitization are crucial measures for understanding receptor activation and differential G protein coupling.
Purpose of the Study:
- To explore the potential of GPCR desensitization/cAMP assays as a versatile platform for high-throughput screening.
- To elucidate novel functions of orphan GPCRs using sensitive assay methodologies.
- To facilitate drug discovery for Gs-coupled GPCRs and understand their physiological roles.
Main Methods:
- Review of GPCR desensitization and cAMP assay methodologies.
- Discussion of the application of these assays in high-throughput screening.
- Analysis of assay sensitivity for screening agonists, partial agonists, and antagonists.
Main Results:
- GPCR desensitization/cAMP assays are highly sensitive and versatile for studying receptor function.
- These assays can identify novel functions of orphan GPCRs.
- The assays provide a simplified system for drug discovery targeting Gs-coupled GPCRs.
Conclusions:
- GPCR desensitization/cAMP assays are powerful tools for advancing GPCR research and drug discovery.
- These assays enhance our understanding of GPCRs' biological effects and therapeutic implications.
- The platform supports the identification of novel therapeutic agents for various diseases involving GPCRs.
More Related Videos
09:03Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
Published on: March 10, 2020
08:46A "Dual-Addition" Calcium Fluorescence Assay for the High-Throughput Screening of Recombinant G Protein-Coupled Receptors
Published on: December 2, 2022